NTCP/SLC10A1 Polyclonal Antibody from Bioss Inc.

Yes, the NTCP/SLC10A1 Polyclonal Antibody has been utilized in studies examining the mechanisms of hepatotoxicity, such as in the research by Gao et al. (2022), where it was used to analyze protein expression related to bile acid metabolism in liver tissues affected by Bakuchiol treatment.

The NTCP/SLC10A1 Polyclonal Antibody has been shown to work in immunohistochemistry, as demonstrated in the study by Lastuvkova et al. (2023), where it was used to assess liver tissue sections for NTCP expression, indicating its suitability for this application.

This antibody is specifically reactive with human tissues, as indicated by its reactivity profile for Homo sapiens. It is designed for use in studies focused on human biology and disease mechanisms.

Yes, the NTCP/SLC10A1 Polyclonal Antibody has been cited in multiple studies, including those investigating the role of bile acid transporters in liver function and cholestasis, such as the work by Kim et al. (2020) and Roth et al. (2024), highlighting its relevance in liver research.